Skip to main content
Fig. 7 | Cardiovascular Diabetology

Fig. 7

From: Empagliflozin suppressed cardiac fibrogenesis through sodium-hydrogen exchanger inhibition and modulation of the calcium homeostasis

Fig. 7

Effects of empagliflozin on heart structure, systolic function, and heart rate of rats with isoproterenol-induced heart failure (HF). Photographs and averaged data present the results of left ventricle fractional shortening (LVFS, statistic test by one − way ANOVA), LV posterior wall (LVPW, statistic test by one − way ANOVA), LV end-diastolic diameter (LVEDD, statistic test by ANOVA on ranks), LV end-systolic diameter (LVESD, statistic test by one − way ANOVA), and heart rate (HR, statistic test by one − way ANOVA) in HF rats receiving vehicles (n = 5), HF rats receiving empagliflozin (n = 5), and control rats (n = 5). * p < 0.05, $ p < 0.005

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840